Form 4: Thomas H. Glocer Reports Acquisition of Phantom Stock in Merck & Co., Inc.

Director Thomas H. Glocer reports the acquisition of phantom stock units in Merck & Co., Inc., settled in cash upon termination of service.

Summary

• Thomas H. Glocer, a director of Merck & Co., Inc., filed a Form 4 on July 2, 2024, reporting a transaction that occurred on June 28, 2024.
• The transaction involved the acquisition of 393.7803 units of phantom stock, which are to be settled 100% in cash upon the reporting person's termination of service.
• The price of the derivative security was $123.8.
• Following the reported transaction, Glocer beneficially owns 96,063.1361 derivative securities.
• Glocer also directly owns 5,100 shares of Merck & Co., Inc. common stock, including shares acquired through dividend reinvestment transactions.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The phantom stock units will be settled in cash upon the reporting person's termination of service, according to a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the holdings and transactions of company directors.

Stakeholder Impact

• The transaction provides transparency to shareholders regarding the director's holdings.

Key Dates